Catalyst Wire Dossier Catalyst Wire Dossier

Fully-human anti-BCMA CAR-T cells

BCMA-directed chimeric antigen receptor T cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fully-human anti-BCMA CAR-T cells, covering 2023-05-15 to 2023-05-15. Get the full timeline:

Most recent: Clinical Trial Update: T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma [Phase 1]

See pricing